A meeting in Massachusetts presented the results of the largest clinical trial of a drug for autism. The drug is called arbaclofen- it works by damping down the excessive brain activity. It derives from the already approved drug- baclofen (used to treat spastic muscles); this means that this class of drugs has already undergone safety testing.
150 people with autism either received a placebo or arbaclofen for 12 weeks. Although this drug did not change social withdrawal of the participants, it did make recipients more able to respond appropriate to other people.
Read in more depth: http://www.autismspeaks.org/science/science-news/top-ten-lists/2012/arbaclofen-shows-promise-treating-core-symptoms-autism
No comments:
Post a Comment